Aquestive Therapeutics In... (AQST)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.04
-0.07 (-2.25%)
At close: Jan 14, 2025, 3:59 PM
3.06
0.49%
After-hours Jan 14, 2025, 04:07 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -7.87M | -54.41M | -70.54M | -55.78M | -66.25M | -61.38M | -8.94M | -9.60M |
Depreciation & Amortization | 1.34M | 2.39M | 2.96M | 3.44M | 2.90M | 3.24M | 3.80M | 3.89M |
Stock-Based Compensation | 2.69M | 4.38M | 6.82M | 6.58M | 7.07M | 29.94M | n/a | n/a |
Other Working Capital | -259.00K | 24.77M | 3.56M | -828.00K | 1.60M | -1.49M | 1.38M | 152.00K |
Other Non-Cash Items | 2.80M | 5.85M | 15.69M | 4.71M | 2.29M | 1.93M | 3.08M | 3.83M |
Deferred Income Tax | n/a | n/a | 13.82M | n/a | 4.90M | 5.28M | n/a | n/a |
Change in Working Capital | -5.34M | 32.01M | -1.73M | -4.41M | -11.12M | 8.00M | 7.88M | -6.29M |
Operating Cash Flow | -6.38M | -9.79M | -32.98M | -45.46M | -60.21M | -12.99M | 5.82M | -8.18M |
Capital Expenditures | -995.00K | -2.52M | -913.00K | -517.00K | -663.00K | -1.82M | -2.07M | -976.00K |
Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.17M |
Other Investing Acitivies | n/a | -1.50M | n/a | n/a | n/a | n/a | n/a | 1.17M |
Investing Cash Flow | -995.00K | -2.52M | -913.00K | -517.00K | -663.00K | -1.82M | -2.07M | 190.00K |
Debt Repayment | -20.39M | n/a | n/a | -22.50M | 17.06M | n/a | 5.00M | 6.94M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 15.45M | -2.02M | 329.00K | 44.74M | -6.77M | -10.79M | -586.00K | -1.25M |
Financial Cash Flow | 3.97M | 11.56M | 30.11M | 28.46M | 49.60M | 58.03M | 4.41M | 5.69M |
Net Cash Flow | -3.40M | -751.00K | -3.78M | -17.52M | -11.27M | 43.22M | 8.17M | -2.30M |
Free Cash Flow | -7.38M | -12.31M | -33.89M | -45.98M | -60.87M | -14.81M | 3.76M | -9.15M |